ACETAMINOPHEN AND IBUPROFEN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Acetaminophen And Ibuprofen, and what generic alternatives are available?
Acetaminophen And Ibuprofen is a drug marketed by Bionpharma, Granules, L Perrigo Co, and Marksans Pharma. and is included in four NDAs.
The generic ingredient in ACETAMINOPHEN AND IBUPROFEN is acetaminophen; ibuprofen. There are sixty-six drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the acetaminophen; ibuprofen profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Acetaminophen And Ibuprofen
A generic version of ACETAMINOPHEN AND IBUPROFEN was approved as acetaminophen; ibuprofen by L PERRIGO CO on February 28th, 2023.
Summary for ACETAMINOPHEN AND IBUPROFEN
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 4 |
| Finished Product Suppliers / Packagers: | 31 |
| Clinical Trials: | 235 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | ACETAMINOPHEN AND IBUPROFEN at DailyMed |
Recent Clinical Trials for ACETAMINOPHEN AND IBUPROFEN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Korea University Guro Hospital | Phase 4 |
| Kyongbo Pharmaceutical Co.,Ltd | Phase 4 |
| Novo Nordisk A/S | Phase 1 |
Pharmacology for ACETAMINOPHEN AND IBUPROFEN
| Drug Class | Nonsteroidal Anti-inflammatory Drug |
| Mechanism of Action | Cyclooxygenase Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for ACETAMINOPHEN AND IBUPROFEN
US Patents and Regulatory Information for ACETAMINOPHEN AND IBUPROFEN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bionpharma | ACETAMINOPHEN AND IBUPROFEN | acetaminophen; ibuprofen | TABLET;ORAL | 216999-001 | Aug 1, 2023 | OTC | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Marksans Pharma | ACETAMINOPHEN AND IBUPROFEN | acetaminophen; ibuprofen | TABLET;ORAL | 216994-001 | Jul 10, 2023 | OTC | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Granules | ACETAMINOPHEN AND IBUPROFEN | acetaminophen; ibuprofen | TABLET;ORAL | 216592-001 | Jul 13, 2023 | OTC | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| L Perrigo Co | ACETAMINOPHEN AND IBUPROFEN | acetaminophen; ibuprofen | TABLET;ORAL | 214836-001 | Feb 28, 2023 | OTC | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
